Type 1 Diabetes at Presentation: the Scene Changes
1990; Wiley; Volume: 7; Issue: 9 Linguagem: Inglês
10.1111/j.1464-5491.1990.tb01488.x
ISSN1464-5491
Autores Tópico(s)Pancreatic function and diabetes
ResumoDiabetic MedicineVolume 7, Issue 9 p. 762-763 Type 1 Diabetes at Presentation: the Scene Changes Paolo Pozzilli, Paolo Pozzilli Endocrinologia I, II Clinica Medica, University of Rome ‘La Sapienza’, Rome, ItalySearch for more papers by this authorDomenico Andreani, Domenico Andreani Endocrinologia I, II Clinica Medica, University of Rome ‘La Sapienza’, Rome, ItalySearch for more papers by this author Paolo Pozzilli, Paolo Pozzilli Endocrinologia I, II Clinica Medica, University of Rome ‘La Sapienza’, Rome, ItalySearch for more papers by this authorDomenico Andreani, Domenico Andreani Endocrinologia I, II Clinica Medica, University of Rome ‘La Sapienza’, Rome, ItalySearch for more papers by this author First published: November 1990 https://doi.org/10.1111/j.1464-5491.1990.tb01488.xCitations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Tarn A., Thomas J., Dean B., et al., Predicting insulin-dependent diabetes. Lancet 1988; i: 845–850. 2 D. Andreani, H. Kolb, P. Pozzilli, eds., Immunotherapy of Type 1 Diabetes. Chichester: John Wiley, 1989. 3 Ziegler A., Ziegler R., Vardi P., Eisenbarth GS., Life table analysis of progression to diabetes of anti-insulin autoantibody positive relatives of individuals with Type 1 diabetes. Diabetes 1989; 38: 1320–1325. 4 Smith CP, Tarn AC, Thomas JM, et al., Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia 1988; 31: 123–125. 5 MacCulloch DK, Palmer JP., Early diagnosis of Type 1 diabetes mellitus. Diabetes Nutr Metab 1989; 2: 245–255. 6 Hamilton DV, Mundia SS, Lister J., Mode of presentation of juvenile diabetes. Br Med J 1976; ii: 211–212. 7 Pozzilli P., Ghirlanda C., on behalf of the IMDIAB Study Group. Immunotherapy of Type 1 diabetes: effect of combined therapy with cyclosporin and nicotinamide (Abstract). Diabetes 1989; 38 (suppl 2): 192A. 8 IDIG Newsletter. Diabetes, Prediction and Therapy, 4 (2), May 1990 (new series). London: International Diabetes Immunotherapy Group. 9 Pozzilli P., Visalli N., Ghirlanda G., Manna R., Andreani D., Nicotinamide increases C-peptide secretion in patients with recent onset Type 1 diabetes. Diabetic Med 1989; 6: 568–572. 10 Sandler S., Andersson A., Longterm effects of exposure of pancreatic islets to nicotinamide in vitro on DNA synthesis, metabolism and beta cell function. Diabetes 1982; 31: 749–753. 11 Atkinson MA, Maclaren NK, Luchetta R., Burr I., Prophylactic insulin therapy prevents insulitis and insulin dependent diabetes (IDD) in NOD mice (Abstract). Diabetes 1989; 38 (suppl 2): 87A. Citing Literature Volume7, Issue9November 1990Pages 762-763 ReferencesRelatedInformation
Referência(s)